药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Butobarbital
Pipenzolate
The risk or severity of adverse effects can be increased when Pipenzolate is combined with Umeclidinium.
Butobarbital
Emetonium iodide
The risk or severity of adverse effects can be increased when Emetonium iodide is combined with Umeclidinium.
Butobarbital
Fenpiverinium
The risk or severity of adverse effects can be increased when Fenpiverinium is combined with Umeclidinium.
Butobarbital
Camylofin
The risk or severity of adverse effects can be increased when Camylofin is combined with Umeclidinium.
Butobarbital
Diphemanil
The risk or severity of adverse effects can be increased when Diphemanil is combined with Umeclidinium.
Butobarbital
Penthienate
The risk or severity of adverse effects can be increased when Penthienate is combined with Umeclidinium.
Butobarbital
Dihexyverine
The risk or severity of adverse effects can be increased when Dihexyverine is combined with Umeclidinium.
Butobarbital
Tiemonium iodide
The risk or severity of adverse effects can be increased when Tiemonium iodide is combined with Umeclidinium.
Butobarbital
Etanautine
The risk or severity of adverse effects can be increased when Etanautine is combined with Umeclidinium.
Butobarbital
Bornaprine
The risk or severity of adverse effects can be increased when Bornaprine is combined with Umeclidinium.
Butobarbital
Rociverine
The risk or severity of adverse effects can be increased when Rociverine is combined with Umeclidinium.
Butobarbital
Bevonium
The risk or severity of adverse effects can be increased when Bevonium is combined with Umeclidinium.
Butobarbital
Poldine
The risk or severity of adverse effects can be increased when Poldine is combined with Umeclidinium.
Butobarbital
Emepronium
The risk or severity of adverse effects can be increased when Emepronium is combined with Umeclidinium.
Butobarbital
Otilonium
The risk or severity of adverse effects can be increased when Otilonium is combined with Umeclidinium.
Butobarbital
Etybenzatropine
The risk or severity of adverse effects can be increased when Etybenzatropine is combined with Umeclidinium.
Butobarbital
Mazaticol
The risk or severity of adverse effects can be increased when Mazaticol is combined with Umeclidinium.
Butobarbital
Phenglutarimide
The risk or severity of adverse effects can be increased when Phenglutarimide is combined with Umeclidinium.
Butobarbital
Difemerine
The risk or severity of adverse effects can be increased when Difemerine is combined with Umeclidinium.
Butobarbital
Benzilone
The risk or severity of adverse effects can be increased when Benzilone is combined with Umeclidinium.